IRIS
DALLIO, MARCELLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.079
AS - Asia 1.756
NA - Nord America 1.439
SA - Sud America 280
AF - Africa 35
OC - Oceania 8
Totale 7.597
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.099
US - Stati Uniti d'America 1.379
SG - Singapore 597
IT - Italia 446
CN - Cina 370
IE - Irlanda 244
VN - Vietnam 233
HK - Hong Kong 230
BR - Brasile 225
KR - Corea 97
DE - Germania 81
JP - Giappone 75
GB - Regno Unito 60
IN - India 53
FR - Francia 35
CA - Canada 30
BD - Bangladesh 27
AR - Argentina 24
NL - Olanda 22
AT - Austria 20
MX - Messico 20
FI - Finlandia 19
ZA - Sudafrica 13
GR - Grecia 12
ID - Indonesia 12
EC - Ecuador 11
IQ - Iraq 11
PK - Pakistan 10
AU - Australia 8
EG - Egitto 8
PL - Polonia 8
TR - Turchia 7
UZ - Uzbekistan 7
ES - Italia 6
PY - Paraguay 6
CO - Colombia 5
SE - Svezia 5
UA - Ucraina 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
KZ - Kazakistan 4
MY - Malesia 4
PE - Perù 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
KE - Kenya 3
LK - Sri Lanka 3
MA - Marocco 3
MK - Macedonia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
ET - Etiopia 2
HN - Honduras 2
IR - Iran 2
KG - Kirghizistan 2
LT - Lituania 2
NP - Nepal 2
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
BS - Bahamas 1
CR - Costa Rica 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 7.597
Salva come PNG Salva come JPEG
Città #
Moscow 1.138
Singapore 301
Dublin 242
San Jose 242
Hong Kong 225
Santa Clara 166
Naples 127
Ashburn 125
Chandler 108
Seoul 97
Ho Chi Minh City 90
Beijing 81
Hefei 76
New York 60
Hanoi 56
Dallas 41
Los Angeles 29
Boardman 28
Bengaluru 27
Princeton 26
Roxbury 25
Munich 22
Bremen 21
Cambridge 21
São Paulo 21
The Dalles 18
Da Nang 17
Nuremberg 16
Orem 16
Rome 15
Caserta 14
Amsterdam 13
Aversa 13
Vienna 13
Paris 12
Council Bluffs 11
Mexico City 11
Boydton 10
Milan 10
Tokyo 10
Montreal 9
Salerno 9
Des Moines 8
Memphis 8
San Francisco 8
Atlanta 7
Belo Horizonte 7
Biên Hòa 7
Chennai 7
Falkenstein 7
Frankfurt am Main 7
Haiphong 7
Helsinki 7
Medford 7
Ninh Bình 7
Tashkent 7
Toronto 7
Turku 7
Warsaw 7
Baghdad 6
Brasília 6
Brooklyn 6
Castellammare di Stabia 6
Fondi 6
Houston 6
Piscataway 6
Sennori 6
Viterbo 6
Bari 5
Boston 5
Hillsboro 5
Lappeenranta 5
Manchester 5
Mumbai 5
Quito 5
Camerino 4
Chengdu 4
Chicago 4
Curitiba 4
Dhaka 4
Groningen 4
Guangzhou 4
Hangzhou 4
Hyderabad 4
Hải Dương 4
Johannesburg 4
London 4
Manassas 4
Manaus 4
Newark 4
Rio de Janeiro 4
Shanghai 4
Sialkot 4
Tianjin 4
Wilmington 4
Astana 3
Asunción 3
Bauru 3
Bisaccia 3
Brno 3
Totale 3.918
Salva come PNG Salva come JPEG
Nome #
Integrating Silybin and Sirtuin Related Pathways in Steatosis-Related Liver Diseases 198
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 180
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 177
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 161
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 156
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 149
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 145
How immunotherapy has changed the continuum of care in hepatocellular carcinoma 145
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 143
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study 141
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 137
Inflammatory Bowel Diseases: The Role of Gut Microbiota 136
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis 136
Light alcohol drinking and the risk of cancer development: a controversial relationship 135
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials 132
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) 132
Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the "Bermuda" triangle of malnutrition-sarcopenia-frailty severely affecting prognosis 130
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 129
Systemic Oxidative Balance Reflects the Liver Disease Progression Status for Primary Biliary Cholangitis (Pbc): The Narcissus Fountain 126
Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications 126
Intestinal pseudo-obstruction as systemic lupus erythematosus complication: is it time to reconsider the role of surgery? A case report of a tailored multidisciplinary managed 44-year-old male patient 125
FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 124
Environmental bisphenol A exposure triggers trained immunity-related pathways in monocytes 124
Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements 124
Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma 122
Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review 120
Exploring the Classic and Novel Pathogenetic Insights of Plastic Exposure in the Genesis and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 120
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 120
Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study 120
Extra-Gastric Manifestations of Helicobacter pylori Infection 119
Risk factors for liver decompensation and hcc in hcv-cirrhotic patients after daas: A multicenter prospective study 117
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 114
Critical review on the use and abuse of alcohol. When the dose makes the difference 113
Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology 113
Systemic Oxidative Stress Correlates with Sarcopenia and Pruritus Severity in Primary Biliary Cholangitis (PBC): Two Independent Relationships Simultaneously Impacting the Quality of Life—Is the Low Absorption of Cholestasis-Promoted Vitamin D a Puzzle Piece? 111
Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)? 110
Nutritional and Psychological Support as a Multidisciplinary Coordinated Approach in the Management of Chronic Liver Disease: A Scoping Review 109
Cirrhosis and frailty assessment in elderly patients: A paradoxical result 109
Nutrigenomics and nutrigenetics in metabolic-(Dysfunction) associated fatty liver disease: Novel insights and future perspectives 107
Spleen Area Affects the Performance of the Platelet Count–Based Non-invasive Tools in Predicting First Hepatic Decompensation in Metabolic Dysfunction–Associated Steatotic Liver Disease Cirrhosis 106
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 106
Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression 105
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial 105
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 102
From “Traditional” to “Trained” Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 100
The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition 98
The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications 98
The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications 97
Urinary volatile Organic compounds in non-alcoholic fatty liver disease (NAFLD), type two diabetes mellitus (T2DM) and NAFLD-T2DM coexistence 96
Letter: Different Risk of Acute Variceal Bleeding According to the Liver Disease Aetiology in Decompensated Cirrhosis Patients Receiving Carvedilol‐Based Primary Prophylaxis—May Insulin Resistance Unloose This Gordian Knot? 96
Is it time to reconsider the MRP6 role in bile secretion and LPAC genetic signature? 94
The role of fructose in non-alcoholic steatohepatitis: Old relationship and new insights 91
Primary biliary cholangitis, Celiac Disease, and MASLD: the triumvirate of steatosis. How should we manage this triple overlap? 89
The role of resveratrol in liver disease: A comprehensive review from in vitro to clinical trials 89
Predicting de‐novo portal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort 88
Beneficial Effects of Long-Lasting Bicarbonate–Sulfate–Calcium–Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcomes via Impacting Intestinal Permeability (IP), IP-Related Systemic Inflammation, and Oxidative Stress 87
Phase Angle/C-reactive Protein-Index as a Novel Combined Tool for Predicting Liver-Related Hospitalizations in MASLD-Decompensated Cirrhosis 87
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV) 83
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease 82
Managing Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease: From “One Size Fits All” to a Multidisciplinary-Tailored Approach 79
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women 79
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm 78
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis 78
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration 72
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease 71
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease 67
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial 65
The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives 26
From “MAFLD” to “MASLD”: Was This Revolution Worth It? A Head-to-Head Comparison of MAFLD and MASLD Criteria in Estimating Liver Disease Progression and Cardiovascular Risk in Real Life 26
Human Albumin-enriched Peritoneal Dialysis: A Novel Approach to Manage Refractory Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease 17
Correction: Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer 15
Risk Factors for Inadequate Bowel Preparation Before Colonoscopy in Patients with Ulcerative Colitis in Clinical and Endoscopic Remission: A Multicenter Retrospective Cohort Study 10
Synbiotic Supplementation for Chronic Constipation in Patients Under Peritoneal Dialysis: An Italian Multicenter Prospective Study 9
Beyond Insulin Resistance: Exploring the Centrality of the Gut–Liver Axis in Mediating Immunometabolic Dysregulation Driving Hepatocellular Carcinoma in MASLD and Diabetes 5
Contrast-enhanced ultrasound as a problem-solving tool and irreversible electroporation for a perivascular/peribiliary segment IVs colorectal liver metastasis: a case report 1
Redefining Liver Transplantation Indications for Hepatic Malignancies in the Era of Precision Transplant Oncology: An Up-to-Date Narrative Review 1
Totale 7.733
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.675
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.675
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/2022201 1 9 8 22 35 15 7 3 6 11 31 53
2022/2023520 39 13 14 37 84 31 0 26 245 7 10 14
2023/2024382 23 10 12 22 59 62 13 1 21 35 40 84
2024/20251.016 6 17 20 46 155 106 140 100 117 126 96 87
2025/20265.492 223 355 279 212 466 2.902 260 238 180 144 138 95
Totale 7.733